APA TO STATES, INSURERS: PROVIDE ACCESS TO MENTAL HEALTH CARE DURING COVID-19 PUBLIC HEALTH CRISIS   

Use of telecommunications will help prevent spread of virus, APA asserts

WASHINGTON — The American Psychological Association called on states and insurers to move quickly to allow people to connect with their mental health providers remotely using telehealth as the need for mental health services rises during the COVID-19 pandemic.  

“We are asking state policymakers to temporarily suspend state licensing requirements for telepsychological services, which would allow patients greater access to their providers and ensure continuity of care during this crisis,” said Arthur C. Evans Jr., PhD, APA’s chief executive officer.  

“The federal government has just identified psychologists as critical, essential workers in the U.S. response to COVID-19. But this does not mean that psychologists and psychology trainees must do work in person," he said. "Essential psychological services can, and in many cases, should be delivered through telehealth. It is critically important that psychologists are able to meet the needs of their patients and communities during this difficult time, without further increasing the risk of contagion.” 

Private insurers should also approve payments for videoconferencing for all providers without limitation, as well as telephone-only services, and psychological and neuropsychological testing, he said.

Advances in telecommunications now allow people to interact with their psychologists through video, telephone and secure messaging platforms. These technological platforms allow people to receive mental health treatment while avoiding the spread of the disease, according to APA. 

Legislation passed by Congress in early March provided psychologists with greater flexibility in providing telehealth services to seniors on Medicare. However, it stopped short of providing similar benefits to those on Medicaid and private insurance. This legislation also did not extend Medicare reimbursement for audio-only services via telephone or for psychological or neuropsychological testing. Many patients and some providers do not have access or capability to use cellphones with video chat. They may also not have internet service or sufficient broadband speed. This is especially true for the many vulnerable populations served by psychologists, including older adults, those with disabilities, people residing in rural areas, those with a lower income, and others.

The federal legislation also does not supersede state licensing laws. Licensed psychologists are typically prohibited from using telehealth to provide services across state lines. APA calls for temporary suspensions of state licensing laws and regulations regarding telepsychological services in order to meet critical needs during the crisis. Some jurisdictions have already issued emergency declarations or have existing temporary practice provisions allowing licensed, out-of-state providers to deliver services during this public health emergency. A number of states have already acted to allow audio-only phone access to telehealth services, in addition to video chat.

“This is an extraordinary public health crisis with vast and unpredictable implications for the nation’s mental health,” Evans said. “Social isolation, grief, fear and stress are already having a real and crippling impact on Americans. Federal and state leaders and insurance companies must take immediate steps to expand access to mental health treatment for all.” 

Government and insurance policies in response to the coronavirus crisis are changing rapidly. APA’s COVID-19 webpage provides frequent updates on this issue. For an up-to-date summary of changes to state-by-state licensing laws, check the Association of State and Provincial Psychology Boards’ web site.
 

Seeking.com Member Sign Ups Up 74 Percent Over Same Time Last Year
Doctors and dating coaches agree that person-to-person communication is essential to mental health during social distancing, explaining an increase on average of 10,000 additional new users per day on the world’s largest Sugar Dating Site, SeekingArrangement. 

March 24, 2020, Las Vegas -- As mandatory shutdowns of all non-essential businesses spread across the globe, and social distancing becomes the norm, tens of millions of singles are forced to find alternative ways to connect and interact with each other. 

Without the ability to meet new people at bars, gyms or other public places, SeekingArrangement provides a platform that allows singles to adapt quickly and stay connected. 

The focus of the dating site has always been to establish meaningful online connections in-order to get comfortable enough to take it to the next level, meeting in-person. Although that’s become increasingly difficult in recent weeks, daters are signing up in droves, finding like-minded adults to escape isolation. While physical distancing is important, the company feels that there has never been a time when we needed to be even more socially and emotionally connected to other human beings.

“Couples (and singles) should increase communication during this physical separation,” says CEO and Founder of Whose Apple Dynamic Coaching and Consulting Services Dr. Linda Williams. “Frankly, many relationships will be tested -- which is not a bad thing at all. This time will either strengthen or show weaknesses in the relationship. Those relationships founded on the physical, rather than a deeper foundation, may prove challenging, But, this is an opportunity to increase emotional intimacy outside of the physical.”

“The importance of making a connection and staying connected during these times is paramount for people susceptible to depression and anxiety,” according to a Pew Research Center study revealing “isolation exacerbates an individual’s level of dissatisfaction with aspects of their personal life, to the extent that they are depression-prone, where isolating them could lead to negative mindsets that get worse the longer they remain isolated.” 

With little insight on when social distancing will end, SeekingArrangement will continue to help support mental health by helping singles meet new people safely, through online engagement.

In a new interview with CMRubinWorld, Steve Mesler, Co-Founder and CEO of Classroom Champions, says all American schools will be able to learn anytime.

NEW YORK (PRWEB) MARCH 24, 2020

Classroom Champions, an organization that supports social and emotional learning (SEL), has launched a new platform and curriculum with Olympic and Paralympic athlete mentors. In a new interview with C.M. Rubin, Founder of CMRubinWorld, Mesler explains that the bottom line for the initiative was to create a safe place that takes the wisdom of athletes who are “walking the talk of perseverance, grit, and leadership,” and provide it to all teachers and schools in the United States. The platform will allow Classroom Champions to put Olympic and Paralympic athlete mentors in front of kids at a time in their lives when they’re most impressionable.

The Classroom Champions platform includes a brand new curriculum with 8 thematic units that focus on real-life evidence-based SEL learning topics for educators to leverage. Units are anchored in athletes’ video lessons supported by lesson plans and other family engagement materials. “There’s no other place where you can learn social and emotional lessons taught by the world’s best,” says Mesler.

Read the full article here                

Steve Mesler is the Co-Founder and CEO of Classroom Champions, a non-profit dedicated to connecting students with world-class athlete mentors. The organization supports social and emotional learning (SEL) and academic achievement, and provides curriculum and mentorship programs to districts, schools, and teachers to encourage children to achieve successful futures. Working with 150+ Olympic, Paralympic, university student-athletes, and professional athletes who volunteer as mentors, Classroom Champions has provided scholarships to Title I, rural, and indigenous communities across the continent. Learn more at: http://www.classroomchampions.org​.                

CMRubinWorld’s award-winning series, The Global Search for Education, brings together distinguished thought leaders in education and innovation from around the world to explore the key learning issues faced by most nations. The series has become a highly visible platform for global discourse on 21st century learning, offering a diverse range of innovative ideas which are presented by the series founder, C. M. Rubin, together with the world’s leading thinkers.

For more information on CMRubinWorld

Follow @CMRubinWorld on Twitter

Contact Information:

David Wine

David(at)cmrubinworld(dot)com

Government of Canada providing financial support towards Medicago's COVID-19 vaccine development

Quebec City biopharmaceutical company moving towards testing stages of COVID-19 vaccine candidate 

QUEBEC CITY, March 24, 2020 /CNW/ - Medicago, a biopharmaceutical company headquartered in Quebec City, welcomes the support from the Government of Canada for the development of a vaccine against COVID-19. On March 12, Medicago announced the successful production of coronavirus Virus-Like-Particle (VLP) in just 20 days after receiving the virus gene, thus having a viable vaccine candidate against COVID-19. 

This Government support will allow Medicago to rapidly move from preclinical testing to clinical trials, as well as scaling up production for pandemic response. 

"We are grateful to the Government of Canada without whom the advancement of this project through the final phase of development would not be possible. The cost of such development is a major obstacle for growing companies like ours which must spend hundred of millions of dollars to bring a product to market," said Dr. Bruce D. Clark, President and CEO of Medicago. "COVID-19 was not on any company's radar, and that's why financial support from governments is so important." 

This past weekend, the Government of Quebec also announced that it would contribute $7 million to help Medicago with the progress of the vaccine.

Medicago is a leader in plant-based technology having previously demonstrated its capability to be a first responder in a flu pandemic. In 2009, the company produced a research-grade vaccine candidate against H1N1 in just 19 days. In 2012, Medicago manufactured 10 million doses of a monovalent influenza vaccine within one month for the Defense Advanced Research Projects Agency (DARPA), part of the U.S. Department of Defense. In 2015, Medicago also demonstrated that it could rapidly produce an anti-Ebola monoclonal antibody cocktail for the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services. 

Medicago's first product, a seasonal recombinant quadrivalent VLP vaccine for active immunization against influenza, is currently under review by Health Canada following the completion of a robust safety and efficacy clinical program involving over 25,000 patients. 

Government of Canada release: https://pm.gc.ca/en/news/news-releases/2020/03/23/canadas-plan-mobilize-science-fight-covid-19

About Medicago 
Medicago is a biopharmaceutical company with more than 450 employees in Canada and the United States. Medicago's mission is to improve global health outcomes by leveraging innovative plant-based technologies for rapid responses to emerging global health challenges. Medicago is committed to advancing therapeutics against life-threatening diseases worldwide. 

For more information: www.medicago.com 

SOURCE Medicago

One-hour coronavirus triage test developed by SQI Diagnostics to receive funding from University Health Network

Grant of $1 million used to finalize development and deployment of existing assay to triage coronavirus patients

TORONTO, March 24, 2020 /CNW/ - SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI"), has been selected by University Health Network ("UHN") investigators to utilize a previously developed SQI assay to assist clinicians in the triaging of patients with COVID-19, the disease caused by the 2019 novel coronavirus (SARS-CoV-2), as well as other forms of respiratory distress. SQI will receive a portion of the almost $1 million grant awarded to UHN by the Canadian Institutes of Health Research (CIHR) to fund the validation and testing of this novel assay, known as Rapid Acute Lung Injury Diagnostic, or "RALI-Dx™."

RALI-Dx, comprised of several biomarkers indicative of acute lung injury, is being studied to determine its ability to accurately predict whether or not a patient experiencing acute respiratory distress caused by COVID-19 or other underlying cause, can be treated and released for self-monitored home care, admitted to a standard hospital unit, or is likely to develop severe life-threatening symptoms requiring immediate intensive care unit (ICU) admittance and advanced respiratory care measures. The test, performed in less than one hour, brings a new level of care that can be deployed in order to triage patients in the currently expanding global coronavirus pandemic. 

According to the American Hospital Association, there are only 46,000 total ICU beds in the United States and demand is said to potentially reach as many as 200,000. It is also estimated that almost one million Americans could require mechanical breathing intervention with the use of ventilator machines. However, according to a paper printed in the Society of Critical Care Medicine, the American healthcare system can only support this need for 135,000 people. The one-hour RALI-Dx test will allow physicians to properly allocate these resources. 

With COVID-19 now a global healthcare crisis, the availability of critical resources such as ICU beds and ventilator machines are quickly becoming more endangered. With a current gap in the ability to objectively identify who requires admission to intensive care vs. who can be safely monitored at-home, hospitals are already facing significant pressure in triaging patients in respiratory distress. RALI-Dx is ideally positioned to fill this need and serve as an indispensable tool to manage limited critical resources in a historic time of need. 

"Joining the global fight against COVID-19 presents a tremendous opportunity for SQI," said Eric Brouwer, PhD, interim CEO of SQI. "Not only is it an opportunity to allow our organization to commercialize an assay we have already developed, but it is also an opportunity to make a positive impact for people around the world."

About SQI Diagnostics

SQI Diagnostics is the life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company's proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide excellent data quality. For more information, please visit www.sqidiagnostics.com. 

Finbold.com Launches a Probability of Getting Coronavirus Calculator

Finbold.com has launched a probability of getting Coronavirus calculator to help individuals from different countries to determine the relative risk of getting the COVID-19 virus on a given day in their country, state or province.How it works

The calculator determines a chance of infection by working out the ratio between new Coronavirus cases in the selected area compared to its population.

Please note, the calculator only takes into consideration new daily cases in each area reported by credible sources to remove all bias from its calculations. Knowing new confirmed cases in each country allows us to work out the actual percentage of people that were infected that day.

“The best way to understand the logic behind the calculator is to compare it to a lottery; if we know that 10 new cases were confirmed on the last day in a country with 10 million people, we know that the chance of  “winning” that day was 1 in a million,” - says Idas Keb, a co-founder at Finbold.com and the creator of the aforementioned tool.

According to Idas, taking any other measurement outside new daily cases confirmed would make the calculator biased. And naturally, there are many other factors that can have an effect on the individual risk of infection, however, this highly depends on the behavior and precaution each individual takes to protect themselves against the virus.Methodology Used 

To determine the relative chance of contracting the virus, the calculator uses the following formula: [chance for the day expressed in %] = [area population] * [new daily cases in the area] / 100.

The data used for calculation is derived from the World Health Organization, CDC and Canada.ca for reported new COVID-19 cases worldwide. And Wikipedia for the updated United States population. To determine the population of other countries, the calculator derives the data from World Population Review.Weighted risk by country

The Coronavirus calculator also allows users to view ranked lists of countries, states and provinces by the chance of infection relative to its population. Risk chance in the lists is expressed in the percentage chance of contracting Coronavirus on a given day.

However, users of the calculator are advised to adhere to all precautions recommended by local authorities and the World Health Organisation to prevent further spread of the virus, regardless of the chance of infection reported by the calculator.

You can find and try the COVID-19 calculator here: https://finbold.com/chance-of-getting-corona-virus-calculator/

Frontline Healthcare Worker Tests Positive for COVID-19

SEIU Healthcare calling for action plan to keep Ontario healthy and secure

RICHMOND HILL, ON, March 23, 2020 /CNW/ - It was confirmed today that a frontline healthcare worker at Markhaven Home for Seniors, located in Markham, has tested positive for COVID-19 after the long-term care home first learned of a resident with the virus last week. Additional workers who may have been exposed to the virus are currently awaiting test results.

The Service Employees International Union (SEIU Healthcare), which represents frontline staff at Markhaven, has been calling on the provincial command table to implement the lessons we learned from SARS to better ensure the protection of workers and the public. SEIU Healthcare is now calling on the government and all health providers to step up with an action plan to keep Ontario healthy and secure, including:

  1. Full Personal Protective Equipment (PPE) for all staff who require it with unit-level infection control plans. 
  2. Government to enforce mandatory protocols through directives, not unenforceable guidance, which only contribute to systemic inconsistencies that put workers and the public at risk. 
  3. Paid administrative leave for all healthcare staff who require isolation and presumptive WSIB coverage for all healthcare workers in Ontario who get sick while fighting COVID-19.  
  4. Table all human resource redeployment plans with workers and their unions to ensure fully staffed shifts for fully safe work environments.  
  5. Ensure the retention of frontline workers by committing to full wage replacement for all homecare workers whose shifts are cancelled through no fault of their own. 

"Today's alarming news is a consequence of a system that is moving too slow to protect workers and the public," says Sharleen Stewart, President of SEIU Healthcare, the union that represents over 60,000 frontline healthcare workers in hospitals, nursing homes, and home and community care. "It's time decision makers put themselves in the shoes of the frontline healthcare workers who are putting themselves in danger to fight the war on COVID-19.  While they fight for us, health system administrators and the provincial government should be there for them. We need a new action plan to meet the moment because efforts to date are falling short and putting families at risk."

SEIU Healthcare represents more than 60,000 healthcare and community service workers across Ontario. The union's members work in hospitals, homecare, nursing and retirement homes, and community services throughout the province. SEIU Healthcare has a strong track record of improving wages, benefits and working conditions for healthcare workers, supporting the training and development needs of its members, and strengthening standards in the management and delivery of patient and client care. www.seiuhealthcare.ca

SOURCE SEIU Healthcare

Community Pharmacists Ask for Patients' Understanding on 30-Day Supplies of Medications

Ontario Pharmacists are Working Together with the Ministry of Health on COVID-19 Response to Ensure Continued Access to Medications for All Ontarians

TORONTO, March 22, 2020 /CNW/ - Pharmacy professionals across the province want to reassure Ontario patients that community pharmacies are here to support them during the COVID-19 pandemic. 

While pharmacists and pharmacy technicians continue to have confidence in our national supply of prescription medication, they are seeing an increased strain on the system due to requests for increased prescription quantities. The majority of provincial governments, Ontario included, have opted to take a precautionary approach to limit quantities of most medications to 30-day supplies to ensure that all patients continue to have their medications. There may be some very limited circumstances where a greater supply is warranted.  

"These are exceptional times. We know that patients are facing enormous challenges. Ontario pharmacists are here to ensure that our patients' continuity of care is not impacted. This requires protecting Ontario's drug supply," says Jen Baker, Chair of Ontario Pharmacists Association. "Limiting prescription medications is a necessary measure to avoid potential shortages." 

Although limiting quantities may pose adjustments for patients and for pharmacies, the public can be assured that Ontario pharmacists will work with them to ensure they receive the care and medication they need.

The Ontario Pharmacists Association is exceptionally proud of the hard work all front-line healthcare professionals are providing, including all pharmacy professionals who are committed to providing care during these challenging times. 

"Many pharmacies offer delivery services and will continue to bring their patients' medications directly to their homes, and not just for those under mandatory self-isolation," says Justin Bates, OPA's Chief Executive Officer. 

"COVID-19 has placed a significant strain on all front-line healthcare sectors, pharmacy included. Demands on pharmacy team members are high, and yet they still show up to work every day on their patients' behalf to ensure that they can receive the continuity of care they absolutely require. We ask that patients work with their pharmacists to ensure that they can continue to receive their medications in a timely and safe manner," says Bates. 

"Pharmacies are fully aware of the anxiety being felt by patients and encourage them to remain home while pharmacists take care of their medication needs. It's a full team effort across Ontario pharmacies. We are asking for patients' understanding at this time. We are all in this together and we'll get through this together," says Bates.

About the Ontario Pharmacists Association

The Ontario Pharmacists Association is committed to evolving the pharmacy profession and advocating for excellence in practice and patient care. With more than 10,000 members, OPA is Canada's largest advocacy organization, and professional development provider for pharmacy professionals across Ontario. By leveraging the unique expertise of pharmacy professionals, enabling them to practise to their fullest potential, and making them more accessible to patients, OPA is working to improve the efficiency and effectiveness of the healthcare system. The pharmacy sector plays a strong role in Ontario with an economic impact of more than $6.3 billion across more than 4,600 community pharmacies, employing 60,000 Ontarians.

SOURCE Ontario Pharmacists Association

Government of Quebec providing $7 million towards Medicago's COVID-19 vaccine development

Quebec City biopharmaceutical company moving towards testing stages of COVID-19 vaccine candidate 

QUEBEC CITY, March 23, 2020 /CNW/ - Medicago, a biopharmaceutical company headquartered in Quebec City, welcomes financial support from the Government of Quebec for the development of a vaccine against COVID-19. On March 12, Medicago announced the successful production of coronavirus Virus-Like-Particle (VLP) in just 20 days after receiving the virus gene, thus having a viable vaccine candidate against COVID-19. 

This funding will allow Medicago to continue research in Quebec, and to initiate preclinical testing to assess the safety and efficacy of the vaccine candidate. The company is focusing its efforts to quickly submit a vaccine candidate to the regulatory authorities. 

"We are extremely grateful to the Government of Quebec for its ongoing commitment to Medicago and its financial support. This financial contribution from Investissement Québec will allow us to quickly start the first phase of testing of our COVID-19 vaccine candidate before initiating clinical trials in humans this summer," said Dr. Bruce D. Clark, President and CEO of Medicago. 

Medicago is a leader in plant-based technology having previously demonstrated its capability to be a first responder in a flu pandemic. In 2009, the company produced a research-grade vaccine candidate against H1N1 in just 19 days. In 2012, Medicago manufactured 10 million doses of a monovalent influenza vaccine within one month for the Defense Advanced Research Projects Agency (DARPA), part of the U.S. Department of Defense. In 2015, Medicago also demonstrated that it could rapidly produce an anti-Ebola monoclonal antibody cocktail for the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services. 

Medicago's first product, a seasonal recombinant quadrivalent VLP vaccine for active immunization against influenza, is currently under review by Health Canada following the completion of a robust safety and efficacy clinical program involving over 25,000 patients. 

About Medicago 
Medicago is a biopharmaceutical company with more than 450 employees in Canada and the United States. Medicago's mission is to improve global health outcomes by leveraging innovative plant-based technologies for rapid responses to emerging global health challenges. Medicago is committed to advancing therapeutics against life-threatening diseases worldwide. 

For more information: www.medicago.com  

SOURCE Medicago

Medzone To Release Hand-Sanitizers With Proceeds Donated to World Health Organization

Medzone, a sports medicine and cosmetic brand, founded in 2001 was originally created to help active people to keep moving forward. In an effort to help fight the spread of the coronavirus, Medzone is currently reviewing and creating unique, high-quality hand hygiene products. With the increase in market need for sanitizers and hand hygiene products, Medzone has created a new line of products including hand sanitizing gel, hand sanitizing spray and foaming hand sanitizers which will be available at www.medzonecorp.com and major national retailers in the coming weeks. MedZone is offering an option to pre-order starting March 23rd.  Medzone is currently working with major retailers for distribution as quickly as possible to help those in need. "We are in regular contact with national retailers and companies in our supply chain to make sure we can deliver high quality products in the earliest time possible." Said Joe Freeman CEO of MedZone. In addition to bringing great products to market that are effective and help customers, the company has committed to donating $0.10 for every hand sanitizer unit sold to the World Health Organization and will donate product to local healthcare professions. "As a company, we wish the best for our customers and all Americans during this unprecedented time. In this difficult period, it's imperative that all of us come together and help our community get through these uncharted waters." said Freeman. The hand sanitizers will range in pricing from $3.99 - $11.99 and are slated to launch late March, pre-order is available now. More information can be found at www. MedZoneCorp.com. 

About MedZone

The mission of MedZone® is to make EveryBody Feel Better. MedZone products work to prevent, treat and manage aches, pains, discomforts, wounds and skin-chafing issues for individuals in sports, industrial settings and recreational activities. The products were initially designed in 2001 based on requests from medical professionals, athletes and in 2002, U.S. Military Special Forces. Over the years the products have been adapted to work for athletes, active people, law enforcement, military and for certain healthcare needs.